In keeping with the spirit of the season, it is with gratitude that I write my first newsletter as the Director of the Tri-Institutional MD-PhD Program. These first few months of my Directorship have truly been a whirlwind, as I have navigated meeting our students in COVID-safe settings, participated in my first white coat ceremony, sampled the delicious (and potent) House libations, and interviewed all of the incredible applicants hoping to join the Tri-I in 2022.
Facing the challenge of another remote summer, Gateways to the Laboratory took the opportunity to rethink our virtual undergraduate research program and introduce innovative new elements to provide a research experience to participants unable to physically be in the labs.
Freddy E. Escorcia, Tri-I MD-PhD graduating class of 2012 and currently a researcher at the National Cancer Institute, has been named among the 2021 Lasker Scholars by a joint project of the Lasker Foundation and the National Institutes of Health.
Sanjeethan "Sanjee" Baksh, eighth year student in the Tri-Institutional MD-PhD Program, has been named 2021 STAT Wunderkind. Dr. Baksh earned his PhD from the Fuchs Lab at The Rockefeller Univeristy in 2020 and will graduate with his MD from Weill Cornell Medicine in 2022.Read more about Sanjee and his award.
The Olaf S. Andersen Physician-Scientist Award was created to honor the legacy of Dr. Olaf S. Andersen, Program Director of the Tri-Institutional MD-PhD Program from 1996 - 2021. The award will be given annually, starting this year, to an MD-PhD student finishing their 3rd year of medical school.There are seven criteria for the award:
On April 8th Weill Cornell Graduate School held the 40th Annual du Vigneaud Research Symposium, this year via remote webcast.The one day symposium featured two poster sessions and two sessions of oral presentations by current WCGS students, along with a keynote address by Dr. Kevan Shokat, of UCSF.
Dr. Katharine (Kathy) Hsu, MD, PhD (Tri-I graduating class of 1994) has been named as the new director of the Tri-Institutional MD-PhD Program. Dr. Hsu, currently a professor at Weill Cornell Graduate School of Medical Sciences and attending hemotologist and oncologist at Memorial Sloan Kettering Cancer Center, where she leads her lab in the study of the ability of natural killer (NK) cells to fight cancer.
NEW YORK (April 9, 2021) — Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.
The Tri-Institutional MD-PhD Program will graduate 13 students in 2021, all of whom have matched in the 2021 Residency Match.The 2021 matches are found below.
